Publication date: Jul 15, 2019
A meta-analysis of 14 studies (16 cohorts) incorporating 1751 participants was performed to evaluate the correlation between baseline neutrophil-to-lymphocyte ratio (NLR) and outcome of immune checkpoint inhibitors (ICI). The pooled hazard ratio (HR) suggested elevated pretreatment NLR was associated with poor OS (HR: 2.61, 95% confidence intervals (CI): 1.77-3.86, p
Xie, X., Liu, J., Yang, H., Chen, H., Zhou, S., Lin, H., Liao, Z., Ding, Y., Ling, L., and Wang, X. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors. 23378. 2019 Cancer Invest.
|Confidence Intervals||Metastatic renal carcinoma|
|HR 2||Branches of biology|
|Meta Analysis||Immune system|
|pathway||BSID||Non-small cell lung cancer|
|disease||DOID||non-small cell lung cancer|
|disease||MESH||non-small cell lung cancer|
|pathway||BSID||Renal cell carcinoma|
|disease||DOID||renal cell carcinoma|
|disease||MESH||renal cell carcinoma|
- Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.
- Will TMB Guide Future Systemic Treatments in Melanoma?
- A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China